ORBi: Detailled Reference

Article (Scientific journals)

Antiagregants: doit-on les arreter avant un acte invasif?

Maeyns, K.; Legrand, Victor; Pierard, Luc et al.

2008 • In Revue Médicale de Liège, 63 (3), p. 136-40

Peer reviewed

Permalink
https://hdl.handle.net/2268/151115

PubMed
18561769

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

MAEYNS_RMLg_2008_63_136.pdf

Publisher postprint (398.05 kB)

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Atherosclerosis/complications/drug therapy; Humans; Platelet Aggregation Inhibitors/administration & dosage/adverse effects; Postoperative Hemorrhage/etiology/prevention & control; Risk Assessment; Thrombosis/etiology/prevention & control

Abstract :

[en] Antiplatelet therapy is the leading therapy for the primary and secondary prevention for the atherosclerotic arterial disease. The practical question of withdraw alavoiding or continuation of oral antiplatelet agents accurs currently before any invasive procedure. It is important to compare the relative thrombotic vs hemorrhagic risk. For most interventions, it is recommended to continue antiplatelet therapy. It is particularly important in patients who benefited from drug-eluting stents where the thrombotic risk is major.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Maeyns, K.

Legrand, Victor ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie

Pierard, Luc ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Lancellotti, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie

Language :

French

Title :

Antiagregants: doit-on les arreter avant un acte invasif?

Alternative titles :

[en] Antiplatelet therapy: should it be withdrawn before any invasive procedure?

Publication date :

2008

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

63

Issue :

3

Pages :

136-40

Peer reviewed :

Peer reviewed

Available on ORBi :

since 21 June 2013

Statistics

Number of views

87 (4 by ULiège)

Number of downloads

505 (5 by ULiège)

More statistics

Scopus citations^®

5

Scopus citations^®
without self-citations

3

OpenAlex citations

0

Bibliography

Biondi-Zoccai G, Lotrionte M, Agostoni P, et al. - A systematic review and meta analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J, 2006, 27, 2667-2674.
Kulbertus H. - L'aspirine:acquisitions récentes en prévention cardiovasculaire. Rev Med Liège, 2004, 59, 695-703.
Patrignani P, Filabozzi P, Patrono C. - Selective cumulative inhibition of platelet thromboxane production by low-dose aspirine in healthy subjects. J clin invest, 1982, 69, 1366-1372.
The Task Force on the use of antiplatelets agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. - Expert consensus document on the use of antiplatelets agents. Eur Heart J, 2004, 25, 166-181.
Collet JP. - Aspirine voor cardiovasculaire preventie : wanneer en voor wie voorschrijven ?. Actualiteit, 2006, 1, 11-15.
De Backer G, Ambrosioni E, Borch-johnson K, et al. - European Guidelines on cardiovascular disease prevention in clinical practice :Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil, 2003, 10, S1-S10.
Daemen J, Wenaweser P, Tsuchida K, et al. - Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice : data from a large two-institutional cohort study. Lancet, 2007, 369, 667-678.
Collet JP, Montalescot G, Tanguy ML, et al. - impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation, 2004, 110, 2361-2367.
Legrand V, Lancellotti P, Waleffe A, et al. - Actualités thérapeutiques en cardiologie. Rev Med Liège, 2007, 62, 244-253.
Cannon C, Mehta S, Aranki S. - Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg , 2005, 80, 768-779.
Brennan M, Wynn R, Miller C, et al. - Aspirin and bleeding in dentistry: an update and recommendations. Surg Oral Med Pathol Oral Radiol Endod, 2007, 104, 316-323.
Ardekian L, Gaspar R, Peled M, et al. - Does low-dose Aspirin therapy complicate oral surgical procedures? JADA, 2000, 131, 331-335.
Kennedy MT, Roche S, Fleming SM, et al. - The association between Aspirine and blood loss in hip fracture patients. Neurol Acta orthop belg, 2006, 72, 29-33.
Burger W, Chemnitius JM, Kneissi GD. - Low-dose Aspirin for cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-Review and Meta- Analysis. J Intern Med, 2005, 257, 399-414.
Katz J, Feldman MA, Bass EB, et al. - Study of Medical Testing for Cataract Surgery Team. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology, 2003, 110, 1784-1788.
Van Damme H, Larbuisson R, Limet R. - La prise en charge cardiaque préopératoire du patient vasculaire. Rev Med Liège, 2003, 58, 409-414.
Chaturvedi S, Bruno A, Feasby T, et al. - Carotid Endarterectomy- an evidence-based review : Report of the Therapeutics and Technology assessment subcommittee of the American Academy of Neurology. Neurology, 2005, 65, 794-801.
Giannarini G, Mogorovich A, Valent F. - Continuing or discontinuing low-dose Aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology, 2007, 70, 501-505.
Kimchi NA, Broide E, Scapa E, et al. - Antiplatelet therapy and the risk of bleeding induced by gastro-intestinal endoscopic procedures: a systematic review of the literature and recommendations. Digestion, 2007, 75, 36-45.

Similar publications